cGxP.wire https://validator.w3.org/feed/docs/rss2.html Aldeyra Plans FDA Dispute Resolution Request for Reproxalap Novo Nordisk Reports Ozempic Cardiovascular Real-World Data AbbVie Highlights Dermatology Research at 2026 EADV Congress Kodiak Sciences Reports Positive Phase 3 Zenkuda Results Innovent Biologics Advances IBI363 in Global Cancer Trials AbbVie Partners With Valkai to Advance AI in Clinical Development Teva Wins FDA Approval for DEGEVMA Biosimilar to Xgeva Ascletis Pharma Reports Positive ASC50 Psoriasis Trial Results Novo Nordisk and Hengrui Pharma Sign $2.6B License Deal Goldenrod Advances 11h Alzheimer’s Research Collaboration Zai Lab to Present Global Zoci Data in First-Line ES-SCLC Nurix Therapeutics Reaches $7 Million Pfizer Collaboration Milestone Immix Biopharma Reports 89% Complete Response Rate With NXC-201 Navigator Medicines Presents NAV-240 and NAV-242 Data at EADV 2026 Castle Biosciences Advances Barrett’s Risk Testing With TissueCypher Invivyd Reports Positive Phase 3 LIBERTY Data for VYD2311 PolarityBio to Present Phase 3 SkinTE Data at SAWC Fall 2026 uniQure Reports 48-Month AMT-130 Data in Huntington’s Disease Cellectar Reports Iopofosine I 131 Data in BTKi-Refractory Waldenström Macroglobulinemia Medicus Pharma Submits Optimized Teverelix Registrational Protocol to FDA Cartesian Reports Durable Descartes-08 Retreatment Data in MG Cognition Therapeutics Schedules FDA Type C Meeting for Zervimesine JCR Gains Japan Orphan Drug Designation for Givinostat Acadia Gains U.S. Patent Allowance for Trofinetide Dosing Verastem Reports Two-Year RAMP 201 Data in LGSOC Eccogene Receives $50M Milestone After Elecoglipron Phase 3 Start AstraZeneca Invests $2 Billion in Summit Therapeutics Kither Biotech Doses First Patients in KIT2014 COPD Trial Cyprumed Oral Delivery Technology Enters Clinical Stage With MSD TransCode Advances TTX-MC138 in Phase 1a Cancer Trial Lakewood-Amedex Reports Positive Nu-3 Antimicrobial Data SetPoint Medical Expands RA Neuroimmune Therapy Access AbbVie Wins FDA Approval for JUVMO in Parkinson’s Disease Caspian Unveils KO-7246 Preclinical Diabetes Data at EASD Nektar Advances Rezpegaldesleukin at EADV Congress 2026 Mirum Advances Brelovitug in Phase 3 HDV Trial Truth Initiative Urges Stronger FDA Review of New Tobacco BRC Therapeutics Advances Botanical Drug Development Mirum Advances Brelovitug in Phase 3 Hepatitis Delta Trial Lupin Receives FDA Approval for Apixaban Oral Suspension Eli Lilly Wins FDA Approval for Once-Weekly Onswik Amlan International Advances Dairy Animal Health at Expo XtalPi Advances KQTD-126 Into FDA IND Review Mirum Pharmaceuticals Wins FDA Approval for ATEBRIOZ HUTCHMED and AstraZeneca Submit US NDA for ORPATHYS Plus TAGRISSO REGENXBIO Reports Three-Year Data for Surabgene in Retinopathy Immuneering Presents Atebimetinib Pancreatic Cancer Data at AACR Castle Biosciences Study Supports Molecular Guidance in AD Henlius Partners With Amberstone on Next-Gen TCEs CervoMed Advances Neflamapimod With New Tablet and FDA Dose Flexibility